Drugs / Brezavvy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06600178 | Jun 2025 → Mar 2026 overdue | coronary microvascular disorder, nonobstructive coronary artery disease | University of Virginia | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Brezavvy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06600178 ↗ |
| Route | Oral | “Brezavvy 20mg oral” NCT06600178 ↗ |